A synergistic approach to prenatal screening
Cell-free DNA Analysis and First Trimester Ultrasound
The first trimester presents a unique window of opportunity to evaluate for fetal anomalies. Advances in ultrasound technology and maternal blood analysis via cell-free DNA (cfDNA) testing have allowed for improved first trimester (FT) evaluation for serious fetal anomalies and more accurate screening for chromosomal conditions compared to first trimester combined screening (FTCS).1
The Voluson™ ultrasound and Harmony® prenatal test are science-backed technologies that complement one another and enable focused and efficient guidance for maternal and fetal care.